Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Future Oncology (London, England)|February 13, 2015
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practiceAlessandra Fabi, Luca Moscetti, Mariangela Ciccarese, et al.Breast Cancer (Dove Medical Press)|January 27, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer TreatmentsLorenzo Belluzzi, Giulio Martinelli, Bianca Medici, et al.Critical Reviews in Oncology/Hematology|December 8, 2015
Current challenges in HER2-positive breast cancerFabio Puglisi, Caterina Fontanella, Vito Amoroso, et al.Cancer Chemotherapy and Pharmacology|July 8, 2005
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II studyAlessandra Felici, Paolo Carlini, Enzo Maria Ruggeri, et al.Future Oncology (London, England)|April 22, 2017
ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational studyLuca Moscetti, Lucia Mentuccia, Patrizia Vici, et al.Cancer Biology & Therapy|August 2, 2018
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patientsClaudia Omarini, Stefania Bettelli, Cecilia Caprera, et al.Oncotarget|September 1, 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applicationsAngela Toss, Federico Piacentini, Laura Cortesi, et al.Current Problems in Cancer|May 26, 2019
The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, ItalyAlessandra Fabi, Gaetano Lanzetta, Enrico Vizza, et al.Journal of Cancer Research and Clinical Oncology|January 4, 2019
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor statusClaudia Omarini, Stefania Bettelli, Cecilia Caprera, et al.Cancer Management and Research|February 4, 2020
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant ChemotherapyClaudia Omarini, Patrizia Palumbo, Annarita Pecchi, et al.Pageof 10